BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perlman RL, Zhao J, Fuller DS, Bieber B, Li Y, Pisoni RL, Robinson BM, Johnson DW, Kawanishi H, Davies SJ, Schreiber MJ, Perl J. International Anemia Prevalence and Management in Peritoneal Dialysis Patients. Perit Dial Int 2019;39:539-46. [PMID: 31582465 DOI: 10.3747/pdi.2018.00249] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, Małyszko J, Swinkels DW, Tarng DC, Cheung M, Jadoul M, Winkelmayer WC, Drüeke TB; Conference Participants. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int 2021;99:1280-95. [PMID: 33839163 DOI: 10.1016/j.kint.2021.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ethier I, Boudville N, McDonald S, Brown F, Kerr PG, Walker R, Holt SG, Badve SV, Cho Y, Hawley C, Robison L, Reidlinger D, Milanzi E, Bieber B, McCullough K, Johnson DW. Representativeness of the PDOPPS cohort compared to the Australian PD population. Perit Dial Int 2021;:8968608211056242. [PMID: 34758648 DOI: 10.1177/08968608211056242] [Reference Citation Analysis]
3 Zhong Z, Luo D, Luo N, Li B, Fu D, Fan L, Li Z, Chen W, Mao H. Serum Hepcidin-25 and Risk of Mortality in Patients on Peritoneal Dialysis. Front Med (Lausanne) 2021;8:684548. [PMID: 34222290 DOI: 10.3389/fmed.2021.684548] [Reference Citation Analysis]
4 Zhu XW, Zhang CX, Xu TH, Jiang GN, Yao L. Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia. World J Clin Cases 2021; 9(26): 7682-7692 [PMID: 34621819 DOI: 10.12998/wjcc.v9.i26.7682] [Reference Citation Analysis]
5 Luo D, Zhong Z, Qiu Y, Wang Y, Li H, Lin J, Chen W, Yang X, Mao H. Abnormal iron status is associated with an increased risk of mortality in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis 2021;31:1148-55. [PMID: 33618923 DOI: 10.1016/j.numecd.2020.12.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Minutolo R, Berto P, Liberti ME, Peruzzu N, Borrelli S, Netti A, Garofalo C, Conte G, De Nicola L, Del Vecchio L, Locatelli F. Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study. J Clin Med 2021;10:1322. [PMID: 33806864 DOI: 10.3390/jcm10061322] [Reference Citation Analysis]
7 Dai S, Chen Y, Hao C, Ge X, Xie Q, Shang D, Zhu T. Addition of roxadustat to erythropoiesis-stimulating agent (ESA) effectively corrects ESA-hyporesponsive anaemia in patients on peritoneal dialysis. J Clin Pharm Ther 2022. [PMID: 35633100 DOI: 10.1111/jcpt.13696] [Reference Citation Analysis]
8 Maruyama Y, Niikura T, Nakashima A, Yamamoto H, Yokoo T. Long-term changes in anemia-related parameters among Japanese dialyzed patients assessed by newly developed web-based system. Ther Apher Dial 2021. [PMID: 34213076 DOI: 10.1111/1744-9987.13705] [Reference Citation Analysis]
9 Diao X, Zheng Z, Yi C, Cao P, Ye H, Liu R, Lin J, Chen W, Mao H, Huang F, Yang X. Association of Abnormal Iron Status with the Occurrence and Prognosis of Peritoneal Dialysis-Related Peritonitis: A Longitudinal Data-Based 10-Year Retrospective Study. Nutrients 2022;14:1613. [DOI: 10.3390/nu14081613] [Reference Citation Analysis]
10 Yang Z, Ma T, Xu X, Fu G, Zhao J, Xu Y, Yang B, Song D, Zhu S, Lv J, Dong J. Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis. Kidney Int Rep 2022;7:455-64. [PMID: 35257058 DOI: 10.1016/j.ekir.2021.12.025] [Reference Citation Analysis]
11 Hou YP, Mao XY, Wang C, Xu ZH, Bu ZH, Xu M, Li B. Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial. J Formos Med Assoc 2021:S0929-6646(21)00250-3. [PMID: 34167878 DOI: 10.1016/j.jfma.2021.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]